BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14725944)

  • 21. Amniotic fluid levels of CA 19.9 and CA 15.3 in normal and Down's syndrome pregnancies.
    Noci I; Borri P; Biagiotti R; Cariati E; Branconi F; Torricelli F; Cappelli G; D'Agata A
    J Perinat Med; 1995; 23(3):237-41. PubMed ID: 8568617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome.
    Sifakis S; Papadopoulou E; Konstantinidou A; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2009 Apr; 19(2):121-5. PubMed ID: 18793862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome.
    Wallace EM; D'Antona D; Shearing C; Evans LW; Thirunavukarasu P; Ashby JP; Shade M; Groome NP
    Clin Endocrinol (Oxf); 1999 May; 50(5):669-73. PubMed ID: 10468934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased amniotic fluid leptin levels in the second trimester in Down's syndrome.
    Choi TY; Kim S; An BM; Jeong SY; Moon HS; Joo BS
    Fetal Diagn Ther; 2009; 26(4):195-9. PubMed ID: 19940449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome.
    Perrone S; Longini M; Bellieni CV; Centini G; Kenanidis A; De Marco L; Petraglia F; Buonocore G
    Clin Biochem; 2007 Feb; 40(3-4):177-80. PubMed ID: 17208212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies.
    Wallace EM; Marjono B; Brown DA; Crossley J; Tong S; Aitken D; Breit S
    Prenat Diagn; 2004 Mar; 24(3):224-6. PubMed ID: 15057958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do amniotic fluid leptin levels decrease in pregnancies with fetal trisomy 21?
    Demir A; Saatli B; Cagliyan E; Solak A; Guclu S
    J Obstet Gynaecol; 2012 Aug; 32(6):540-2. PubMed ID: 22779957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death.
    Florio P; Michetti F; Bruschettini M; Lituania M; Bruschettini P; Severi FM; Petraglia F; Gazzolo D
    Lancet; 2004 Jul 17-23; 364(9430):270-2. PubMed ID: 15262105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amniotic fluid and maternal serum levels of CA125 in pregnancies affected by Down syndrome: a re-evaluation of the role of CA125 in Down syndrome screening.
    Spencer K; Muller F; Aitken DA
    Prenat Diagn; 1997 Aug; 17(8):701-6. PubMed ID: 9267892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S100B testing in pregnancy.
    Michetti F; Gazzolo D
    Clin Chim Acta; 2003 Sep; 335(1-2):1-7. PubMed ID: 12927678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High immunocontent of S100 beta protein in amniotic fluid of pregnancies with Down syndrome.
    Portela LC; Tort AB; Neto EC; Kessler RG; Penchaszadeh V; Souza DO; Gonçalves CA; Giugliani R
    Ultrasound Obstet Gynecol; 2000 Nov; 16(6):590-2. PubMed ID: 11220205
    [No Abstract]   [Full Text] [Related]  

  • 32. S100B protein expression in the amnion and amniotic fluid in pregnancies complicated by pre-eclampsia.
    Tskitishvili E; Komoto Y; Temma-Asano K; Hayashi S; Kinugasa Y; Tsubouchi H; Song M; Kanagawa T; Shimoya K; Murata Y
    Mol Hum Reprod; 2006 Dec; 12(12):755-61. PubMed ID: 17023485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome.
    Tsangaris GT; Karamessinis P; Kolialexi A; Garbis SD; Antsaklis A; Mavrou A; Fountoulakis M
    Proteomics; 2006 Aug; 6(15):4410-9. PubMed ID: 16847874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome.
    Yamamoto R; Azuma M; Wakui Y; Kishida T; Yamada H; Okuyama K; Sagawa T; Shimizu K; Satomura S; Fujimoto S
    Clin Chim Acta; 2001 Feb; 304(1-2):137-41. PubMed ID: 11165209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amniotic fluid NF-kB concentration in pregnant women with a high risk of prenatal screening test results.
    Arpacı H; Yapca OE
    Ginekol Pol; 2018; 89(10):577-580. PubMed ID: 30393848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100beta protein and amniotic fluid.
    Benn P
    Clin Chim Acta; 2003 Sep; 335(1-2):169. PubMed ID: 12927700
    [No Abstract]   [Full Text] [Related]  

  • 37. Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome.
    Davis RO; Cosper P; Huddleston JF; Bradley EL; Finley SC; Finley WH; Milunsky A
    Am J Obstet Gynecol; 1985 Nov; 153(5):541-4. PubMed ID: 2414991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amniotic fluid and umbilical cord serum erythropoietin in term and prolonged pregnancies.
    Seikku L; Stefanovic V; Rahkonen P; Teramo K; Paavonen J; Tikkanen M; Rahkonen L
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():1-5. PubMed ID: 30529256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
    Martínez-Morillo E; Cho CK; Drabovich AP; Shaw JL; Soosaipillai A; Diamandis EP
    J Proteome Res; 2012 Jul; 11(7):3880-7. PubMed ID: 22681384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
    Cho CK; Smith CR; Diamandis EP
    J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.